Joshi I, Peravali M, Geng X, Rao S, et al. Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy. Clin Lung Cancer 2022;23:438-445.
PMID: 35649819